ER study aims to stop patients being awake and paralyzed on ventilators

NCT ID NCT05534243

Recruiting now Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using a short-acting paralytic drug (succinylcholine) instead of a longer-acting one (rocuronium) can prevent patients from being awake while paralyzed during emergency breathing support. About 3,090 adults on ventilators in emergency departments will take part. The goal is to reduce traumatic memories and post-traumatic stress disorder (PTSD) after their hospital stay.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AWARENESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

palsy post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AWARENESS INTUBATION COMPLICATION MECHANICAL VENTILATION PTSD

Contacts and locations

Locations

Cooper University Hospital/Cooper Medical School of Rowan University
RECRUITING

Camden, New Jersey, 08103, United States
Hennepin Healthcare
RECRUITING

Minneapolis, Minnesota, 55415, United States
Roy J. and Lucille A. Carver College of Medicine
RECRUITING

Iowa City, Iowa, 52242, United States
University of Washington School of Medicine
RECRUITING

Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.